Entry |
|
Name |
L-Isoleucine;
2-Amino-3-methylvaleric acid
|
Formula |
C6H13NO2
|
Exact mass |
131.0946
|
Mol weight |
131.17
|
Structure |
|
Remark |
|
Reaction |
|
Pathway |
map00280 | Valine, leucine and isoleucine degradation |
map00290 | Valine, leucine and isoleucine biosynthesis |
map00960 | Tropane, piperidine and pyridine alkaloid biosynthesis |
map01060 | Biosynthesis of plant secondary metabolites |
map01064 | Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid |
map01110 | Biosynthesis of secondary metabolites |
map01210 | 2-Oxocarboxylic acid metabolism |
map04974 | Protein digestion and absorption |
map05230 | Central carbon metabolism in cancer |
|
Module |
M00019 | Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine |
M00570 | Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine |
|
Network |
nt06024 Valine, leucine and isoleucine degradation |
Enzyme |
|
Brite |
Compounds with biological roles [BR:br08001]
Peptides
Amino acids
Common amino acids
C00407 Isoleucine (Ile)
Risk category of Japanese OTC drugs [BR:br08312]
Third-class OTC drugs
Inorganic and organic chemicals
L-Isoleucine
D00065 Isoleucine (USP)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00065 L-Isoleucine
|
Other DBs |
|
KCF data |
ATOM 9
1 C1c C 22.4922 -17.1397
2 C1c C 23.6796 -16.4029
3 C6a C 21.2581 -16.4789
4 N1a N 22.5391 -18.5377
5 C1b C 24.9137 -17.0637
6 C1a C 23.6387 -15.0049
7 O6a O 20.1001 -17.2742
8 O6a O 21.2815 -15.0809
9 C1a C 26.1069 -16.3268
BOND 8
1 1 2 1
2 1 3 1
3 1 4 1 #Down
4 2 5 1
5 2 6 1 #Up
6 3 7 1
7 3 8 2
8 5 9 1
|